Hepatitis C Virus Infection clinical trials

Explore recruiting hepatitis c virus infection clinical trials.

Recruiting hepatitis c virus infection studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hepatitis C Virus Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Open-Label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects with Chronic Hepatitis C Virus (HCV) Infection

Romania, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study

Romania, France, Germany, Greece, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hepatitis C Virus Infection trials by city

Hepatitis C Virus Infection clinical trials

Recruiting hepatitis c virus infection studies right now

Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)

Hepatitis C Tracker Study

Persuasive Health Communication Intervention for HIV/HCV

California MEPS Hub

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings

Also recruiting in Europe

A Phase 2, Open-Label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects with Chronic Hepatitis C Virus (HCV) Infection

An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study

Hepatitis C Virus Infection trials by city

Other conditions